Literature DB >> 8622853

New insights into p53 function from structural studies.

C H Arrowsmith1, P Morin.   

Abstract

Recent structural analysis of p53 has greatly enhanced our understanding of the biochemical activities of this protein by presenting us with a detailed picture of the chemical groups in the protein that are involved in protein stability, conformation and functional interactions. The current structures form the basis for the design of potential therapeutics which could, for example, revert a DNA-binding mutant back to a DNA-binding competent conformation. The structure of the tet domain forms the basis for designing an active therapeutic p53 with an oligomerization domain which would not cross react with a DNA-binding mutant p53. However, as useful as these structures have been in providing insight into the structure/function relationship for p53, a complete understanding of this protein awaits more detailed information on the full-length protein. In this respect, one of the most useful roles for future structural studies will be to help identify the nature of the conformational transition between latent and active p53, and how it can be modulated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622853

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.

Authors:  M G Mateu; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.

Authors:  M G Mateu; A R Fersht
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  How p53 binds DNA as a tetramer.

Authors:  K G McLure; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

4.  Assignment of 1H(N), 15N, 13C(alpha), 13CO and 13C(beta) resonances in a 67 kDa p53 dimer using 4D-TROSY NMR spectroscopy.

Authors:  F A Mulder; A Ayed; D Yang; C H Arrowsmith; L E Kay
Journal:  J Biomol NMR       Date:  2000-10       Impact factor: 2.835

5.  p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?

Authors:  J Bian; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 6.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Apoptosis by p53: mechanisms, regulation, and clinical implications.

Authors:  R V Sionov; Y Haupt
Journal:  Springer Semin Immunopathol       Date:  1998

8.  NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain.

Authors:  Pamela D Vise; Bharat Baral; Andrew J Latos; Gary W Daughdrill
Journal:  Nucleic Acids Res       Date:  2005-04-11       Impact factor: 16.971

9.  Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Authors:  J F Mirjolet; M Barberi-Heyob; C Didelot; J P Peyrat; J Abecassis; R Millon; J L Merlin
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  Stability of the core domain of p53: insights from computer simulations.

Authors:  Arumugam Madhumalar; Derek John Smith; Chandra Verma
Journal:  BMC Bioinformatics       Date:  2008       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.